Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.

This is the first publication to compare PD-L1 and PD-L2 expression in primary OSCC and matched LNM. The results indicate that anti-PD-1 therapy may be of therapeutic use even in early stage OSCC to prevent further progression.